OP0228 Comparative risk of biologic therapies and risk of glucocorticoids in patients with rheumatoid arthritis undergoing elective arthroplasty | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Citation Tools

FRIDAY, 15 JUNE 2018

Biologics in RA. More, more and more about safety

OP0228 Comparative risk of biologic therapies and risk of glucocorticoids in patients with rheumatoid arthritis undergoing elective arthroplasty

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: George M, Baker J, Winthrop K, et al

OP0228 Comparative risk of biologic therapies and risk of glucocorticoids in patients with rheumatoid arthritis undergoing elective arthroplasty

Annals of the Rheumatic Diseases 2018;77:163.